Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-11-30

Clinical Trial Update: Efficacy and Safety of Cinitapride Tablets in the Treatment of Mild to Moderate Functional Dyspepsia [Phase 3]

View source ↗

Summary

A Phase 3 trial assessed the efficacy and safety of Cinitapride tablets for mild-to-moderate functional dyspepsia and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cinitapride (cinitapride)

Snippet

Sponsor: Eisai China Inc. | Conditions: Dyspepsia | Phase 3 | Status: COMPLETED